Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 56 Records) |
| Query Trace: Lung Neoplasms and CYP2A6[original query] |
|---|
| Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms. Human molecular genetics 2014 Jan 23 (2): 555-61. Bloom A Joseph, Baker Timothy B, Chen Li-Shiun, Breslau Naomi, Hatsukami Dorothy, Bierut Laura J, Goate Alis |
| Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis. Molecular biology reports 2013 Sep 40 (9): 5255-9. Liu Zheng-Bing, Shu Jun, Wang Li-Ping, Jin Cheng, Lou Zhi-X |
| CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 2651-7. Liu Yu-liang, Xu Yu, Li Fan, Chen Hong, Guo Shu-lia |
| Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. International journal of molecular sciences 2013 14 (4): 8381-92. Wassenaar Catherine A, Dong Qiong, Amos Christopher I, Spitz Margaret R, Tyndale Rachel |
| Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis. PloS one 2013 8 (4): e59556. Wang Lishan, Zang Weidong, Liu Jiang, Xie Dongli, Ji Weidong, Pan Yaosheng, Li Zhiqiang, Shen Jiawei, Shi Yongyo |
| Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with dual-labeled probes. Clinica chimica acta; international journal of clinical chemistry 2015 Feb 441 71-4. Shimizu Makiko, Sawaya Ren, Kishimoto Izumi, Yamazaki Hiros |
| CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. Carcinogenesis 2015 Jan 36 (1): 99-103. Wassenaar Catherine A, Ye Yuanqing, Cai Qiuyin, Aldrich Melinda C, Knight Joanne, Spitz Margaret R, Wu Xifeng, Blot William J, Tyndale Rachel |
| A DRD1 polymorphism predisposes to lung cancer among those exposed to secondhand smoke during childhood. Cancer prevention research (Philadelphia, Pa.) 2014 Dec 7 (12): 1210-8. Robles Ana I, Yang Ping, Jen Jin, McClary Andrew C, Calhoun Kara, Bowman Elise D, Vähäkangas Kirsi, Greathouse K Leigh, Wang Yi, Olivo-Marston Susan, Wenzlaff Angela S, Deng Bo, Schwartz Ann G, Ryan Bríd |
| Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. PloS one 2015 10 (7): e0126113. Bergen Andrew W, Michel Martha, Nishita Denise, Krasnow Ruth, Javitz Harold S, Conneely Karen N, Lessov-Schlaggar Christina N, Hops Hyman, Zhu Andy Z X, Baurley James W, McClure Jennifer B, Hall Sharon M, Baker Timothy B, Conti David V, Benowitz Neal L, Lerman Caryn, Tyndale Rachel F, Swan Gary E, |
| CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers. Drug metabolism and pharmacokinetics 2015 Aug 30 (4): 263-8. Hosono Hiroki, Kumondai Masaki, Arai Tomio, Sugimura Haruhiko, Sasaki Takamitsu, Hirasawa Noriyasu, Hiratsuka Masahi |
| Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study. International journal of cancer. Journal international du cancer 2015 Dec . Yuan Jian-Min, Nelson Heather H, Butler Lesley M, Carmella Steven G, Wang Renwei, Kuriger-Laber Jacquelyn K, Adams-Haduch Jennifer, Hecht Stephen S, Gao Yu-Tang, Murphy Sharon |
| Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers. Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
Cancer research 2016 Oct 76 (19): 5768-5776. Patel Yesha M, Park Sunghim L, Han Younghun, Wilkens Lynne R, Bickeböller Heike, Rosenberger Albert, Caporaso Neil, Landi Maria Teresa, Brüske Irene, Risch Angela, Wei Yongyue, Christiani David C, Brennan Paul, Houlston Richard, McKay James, McLaughlin John, Hung Rayjean, Murphy Sharon, Stram Daniel O, Amos Christopher, Le Marchand Lo |
| Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity. Carcinogenesis 2016 Mar 37 (3): 269-279. Park Sungshim L, Tiirikainen Maarit I, Patel Yesha M, Wilkens Lynne R, Stram Daniel O, Le Marchand Loic, Murphy Sharon |
| CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study. Carcinogenesis 2017 Feb . Yuan Jian-Min, Nelson Heather H, Carmella Steven G, Wang Renwei, Kuriger-Laber Jacquelyn, Jin Aizhen, Adams-Haduch Jennifer, Hecht Stephen S, Koh Woon-Puay, Murphy Sharon |
| Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer. Pharmacogenetics and genomics 2017 Feb . Tanner Julie-Anne, Henderson Jeffrey A, Buchwald Dedra, Howard Barbara V, Nez Henderson Patricia, Tyndale Rachel |
| Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6. Chemical research in toxicology 2017 Jan 30 (1): 410-419. Murphy Sharon |
| Genetic Polymorphism of CYP2A6 and Its Relationship with Nicotine Metabolism in Male Bataknese Smokers Suffered from Lung Cancer in Indonesia. Open access Macedonian journal of medical sciences 2018 Jul 6 (7): 1199-1205. Soeroso Noni Novisari, Zain-Hamid Rozaimah, Sinaga Bintang Y M, Sadewa Ahmad Hamim, Syafiuddin Tamsil, Syahruddin Elisna, Tann Gino, Mutiara Er |
| Genome-wide association study of familial lung cancer.
Carcinogenesis 2018 Jun . Byun Jinyoung, Schwartz Ann G, Lusk Christine, Wenzlaff Angela S, de Andrade Mariza, Mandal Diptasri, Gaba Colette, Yang Ping, You Ming, Kupert Elena Y, Anderson Marshall W, Han Younghun, Li Yafang, Qian David, Stilp Adrienne, Laurie Cathy, Nelson Sarah, Zheng Wenying, Hung Rayjean J, Gaborieau Valerie, Mckay James, Brennan Paul, Caporaso Neil E, Landi Maria Teresa, Wu Xifeng, McLaughlin John R, Brhane Yonathan, Bossé Yohan, Pinney Susan M, Bailey-Wilson Joan E, Amos Christopher |
| Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population. BMC cancer 2018 May 18 (1): 525. Ezzeldin Nada, El-Lebedy Dalia, Darwish Amira, El Bastawisy Ahmed, Abd Elaziz Shereen Hamdy, Hassan Mirhane Mohamed, Saad-Hussein Am |
| HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers. Thoracic cancer 2019 Feb . Hua Feng, Guo Yonglu, Sun Qiang, Yang Leizhou, Gao Fa |
| Genetically determined metabolism of nicotine and its clinical significance. Acta biochimica Polonica 2019 10 66 (4): 375-381. Delijewski Marcin, Barto? Aleksandra, Delijewska Paulina, Balwierz Rados?aw, Jakubiak Grzegorz, Ko?mider Leon, Pawlas Natal |
| Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme. Genetic epidemiology 2020 8 44 (7): 748-758. Bray Michael J, Chen Li-Shiun, Fox Louis, Hancock Dana B, Culverhouse Robert C, Hartz Sarah M, Johnson Eric O, Liu Mengzhen, McKay James D, Saccone Nancy L, Hokanson John E, Vrieze Scott I, Tyndale Rachel F, Baker Timothy B, Bierut Laura |
| Cytochrome P450 2A6 whole-gene deletion (CYP2A6*4) polymorphism reduces risk of lung cancer: A meta-analysis. Tobacco induced diseases 2020 6 18 50. Johani Fadzrul H, Majid Mohd S A, Azme Muhammad H, Nawi Azmawati |
| Pharmacogenetics of the cytochromes P450: Selected pharmacological and toxicological aspects. Advances in pharmacology (San Diego, Calif.) 2022 8 95 49-72. Daly Ann |
| Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer.
Nature genetics 2022 08 54 (8): 1167-1177. Byun Jinyoung, Han Younghun, Li Yafang, Xia Jun, Long Erping, Choi Jiyeon, Xiao Xiangjun, Zhu Meng, Zhou Wen, Sun Ryan, Bossé Yohan, Song Zhuoyi, Schwartz Ann, Lusk Christine, Rafnar Thorunn, Stefansson Kari, Zhang Tongwu, Zhao Wei, Pettit Rowland W, Liu Yanhong, Li Xihao, Zhou Hufeng, Walsh Kyle M, Gorlov Ivan, Gorlova Olga, Zhu Dakai, Rosenberg Susan M, Pinney Susan, Bailey-Wilson Joan E, Mandal Diptasri, de Andrade Mariza, Gaba Colette, Willey James C, You Ming, Anderson Marshall, Wiencke John K, Albanes Demetrius, Lam Stephan, Tardon Adonina, Chen Chu, Goodman Gary, Bojeson Stig, Brenner Hermann, Landi Maria Teresa, Chanock Stephen J, Johansson Mattias, Muley Thomas, Risch Angela, Wichmann H-Erich, Bickeböller Heike, Christiani David C, Rennert Gad, Arnold Susanne, Field John K, Shete Sanjay, Le Marchand Loic, Melander Olle, Brunnstrom Hans, Liu Geoffrey, Andrew Angeline S, Kiemeney Lambertus A, Shen Hongbing, Zienolddiny Shanbeh, Grankvist Kjell, Johansson Mikael, Caporaso Neil, Cox Angela, Hong Yun-Chul, Yuan Jian-Min, Lazarus Philip, Schabath Matthew B, Aldrich Melinda C, Patel Alpa, Lan Qing, Rothman Nathaniel, Taylor Fiona, Kachuri Linda, Witte John S, Sakoda Lori C, Spitz Margaret, Brennan Paul, Lin Xihong, McKay James, Hung Rayjean J, Amos Christopher |
| Genotyping, characterization, and imputation of known and novel CYP2A6 structural variants using SNP array data. Journal of human genetics 2023 4 . Langlois Alec W R, El-Boraie Ahmed, Pouget Jennie G, Cox Lisa Sanderson, Ahluwalia Jasjit S, Fukunaga Koya, Mushiroda Taisei, Knight Jo, Chenoweth Meghan J, Tyndale Rachel |
| CYP2A6 activity and cigarette consumption interact in smoking-related lung cancer susceptibility. Cancer research 2023 12 . Mulong Du, Junyi Xin, Rui Zheng, Qianyu Yuan, Zhihui Wang, Hongliang Liu, Hanting Liu, Guoshuai Cai, Demetrius Albanes, Stephen Lam, Adonina Tardon, Chu Chen, Stig E Bojesen, Maria Teresa Landi, Mattias Johansson, Angela Risch, Heike Bickeböller, H-Erich Wichmann, Gad Rennert, Susanne Arnold, Paul Brennan, John K Field, Sanjay S Shete, Loïc Le Marchand, Geoffrey Liu, Angeline S Andrew, Lambertus A Kiemeney, Shanbeh Zienolddiny, Kjell Grankvist, Mikael Johansson, Neil E Caporaso, Angela Cox, Yun-Chul Hong, Jian-Min Yuan, Matthew B Schabath, Melinda C Aldrich, Meilin Wang, Hongbing Shen, Feng Chen, Zhengdong Zhang, Rayjean J Hung, Christopher I Amos, Qingyi Wei, Philip Lazarus, David C Christia |
| Associating CYP2A6 structural variants with ovarian and lung cancer risk in the UK Biobank: replication and extension. European journal of human genetics : EJHG 2023 12 . Alec W R Langlois, Jennie G Pouget, Jo Knight, Meghan J Chenoweth, Rachel F Tynda |
| CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients. Frontiers in pharmacology 2023 11 14 1222435. Teerapat Majam, Chonlaphat Sukasem, Thanyanan Reungwetwattana, Phichai Chansriwong, Chalirmporn Atasilp, Narumol Trachu, Thanaporn Thamrongjirapat, Rattanaporn Sukprasong, Jennis Meanwattha |
- Page last reviewed:Feb 1, 2024
- Content source: